logo
  

Peabody Energy, Glencore To Form Joint Venture

Coal company Peabody Energy (BTU) Monday announced an agreement to establish a joint venture between Peabody's Wambo Open-Cut Mine and Glencore Plc's (GLCNF, GLNCY, GLEN.L) United Mine in New South Wales, Australia. The joint venture is expected to deliver significant synergies by improving productivity, lowering costs and extending mine life.

The 50-50 joint venture will combine Wambo's Open-Cut mining operations with United's adjacent reserves in the Hunter Valley. Glencore will manage the combined mining operations utilizing Wambo Open-Cut Mine's existing infrastructure, and Peabody will continue to operate coal washing and loading facilities. The project is anticipated to commence in 2017, subject to regulatory permitting. Peabody's North Wambo Underground operations are not affected.

"Peabody continues to take positive steps to further reduce costs, improve our competitive position and create value," said Peabody Energy President and Chief Operating Officer Glenn Kellow. "This combined operation is expected to deliver substantial synergies to both parties while providing ongoing local employment opportunities and economic contributions."

Peabody's share of the combined operation's output is expected to remain consistent with Wambo Open-Cut Mine's historical volumes of approximately 3 million tons per year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT